(AUSTIN) — The Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its 200th CPRIT Scholar to Texas. Theresa Guise, M.D., a leading physician scientist in the study of skeletal complications of cancer, including bone metastasis, bone loss and muscle weakness has accepted a CPRIT Established Investigator Award to join The University of Texas MD Anderson Cancer Center from Indiana University School of Medicine.
"CPRIT Scholars have bolstered the life sciences ecosystem in Texas, bringing talented individuals and their scientific knowledge to build a critical mass in the fight against cancer,” said Dr. James Willson, CPRIT Chief Scientific Officer. “I welcome Dr. Guise to Texas, and she joins a long line of researchers who have grounded themselves here and continue to provide invaluable contributions for better understanding the science behind cancer and how it can be successfully treated."
Dr. Guise has received multiple honors and awards in recognition of her contributions to bone research including an NIH Outstanding Investigator Award and a Komen Scholar Award. Her pioneering work has helped to explain mechanisms by which metastatic tumors destroy bone and has contributed to FDA approved therapies for metastatic disease.
CPRIT’s recruitment awards bring top talent in cancer research to Texas and are used to attract the finest cluster of cancer researchers in the world. Recruits accepting the awards are given the prestigious “CPRIT Scholar” designation. CPRIT awards three types of recruitment grants: Established Investigators for senior research faculty with distinguished professional careers and established cancer research programs; Rising Stars for early-stage investigators who have demonstrated promising continued and enhanced contributions to the field; and First Time, Tenure Track Faculty for emerging investigators pursuing their first faculty appointment who are expected to make outstanding contributions in cancer research.
The impact of CPRIT Scholars:
- Recruited to 18 institutions across Texas
- 97% retention rate
- International/National Awards include: the Nobel Prize in Physiology or Medicine 2018; National Academies (9); Howard Hughes Medical Institute (2)
- $437,943,174 raised in non-state follow-on funds
- 1,232 published publications
- 212 filed patents
- 20 clinical studies
- 2,076 patients
To learn more about CPRIT Scholars at Texas institutions and the vital contribution they make to cancer research, please visit http://scholars.cprit.texas.gov.
About the Cancer Prevention and Research Institute of Texas
To date, CPRIT has awarded $2.43 billion in grants to Texas research institutions and organizations through its academic research, prevention, and product development research programs. CPRIT has recruited 200 distinguished researchers, supported the establishment, expansion or relocation of 36 companies to Texas, and generated over $4.5 billion in additional public and private investment. CPRIT funding has advanced scientific and clinical knowledge and provided 5.9 million life-saving cancer prevention and early detection services reaching Texans from all 254 counties. On November 5, 2019, Texas voters overwhelmingly approved a constitutional amendment to reauthorize CPRIT and provide an additional $3 billion for a total $6 billion investment in cancer research and prevention.